RapidRatings

This issue's key takeaways: A financially unstable supplier may disrupt a supply chain long before bankruptcy is even considered One vulnerable supplier can cause serious repercussions for companies throughout a supply chain’s ecosystem Companies that perform proactive and continuous analysis of its their suppliers’ financial health will detect issues earlier and mitigate the damage more effectively Moreover, the companies that do this well will be much better positioned to grow with their suppliers, having mitigated risk but created the most resilient supply chain possible

For those who were watching closely, Luminar’s imminent bankruptcy isn’t sudden at all.

This issue's key takeaways: Macro-level trends and a challenging economic landscape have strained supply chains. In Europe, public and private company financial health has gone down. Financial health informs all risk domains. Detecting supply chain risk is key to effectively managing it.

The pharmaceutical supply chain stands apart from all others. When disruptions occur, the stakes aren't just financial, they're life and death. Healthcare companies depend on a seamless flow of goods to deliver critical patient care, making pharma supply chain resilience a human imperative.